Tetsuro Ito

686 total citations · 1 hit paper
42 papers, 427 citations indexed

About

Tetsuro Ito is a scholar working on Information Systems, Artificial Intelligence and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tetsuro Ito has authored 42 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Information Systems, 8 papers in Artificial Intelligence and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tetsuro Ito's work include Web Data Mining and Analysis (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Prostate Cancer Treatment and Research (7 papers). Tetsuro Ito is often cited by papers focused on Web Data Mining and Analysis (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Prostate Cancer Treatment and Research (7 papers). Tetsuro Ito collaborates with scholars based in United Kingdom, Belgium and Japan. Tetsuro Ito's co-authors include Joris Diels, Suzy Van Sanden, Albino J. Oliveira‐Maia, Makoto Nakashima, Andreas Reif, Allan H. Young, István Bitter, Jozefien Buyze, Fred Saad and Pierre‐Michel Llorca and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Tetsuro Ito

36 papers receiving 407 citations

Hit Papers

Esketamine Nasal Spray versus Quetiapine for Treatment-Re... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
    2023 110 citations Andreas Reif, István Bitter et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuro Ito United Kingdom 12 105 100 61 57 55 42 427
Pallav Bhatnagar United States 14 36 0.3× 233 2.3× 178 2.9× 18 0.3× 125 2.3× 28 1.2k
Boris Oskotsky United States 8 76 0.7× 10 0.1× 122 2.0× 33 0.6× 11 0.2× 12 747
Brian Hurley United States 10 78 0.7× 20 0.2× 197 3.2× 13 0.2× 33 0.6× 39 779
Matthew M. Hutmacher United States 14 27 0.3× 40 0.4× 76 1.2× 3 0.1× 46 0.8× 31 554
Carol Reid United Kingdom 11 25 0.2× 34 0.3× 12 0.2× 60 1.1× 12 0.2× 25 779
Enrique J. deAndrés‐Galiana Spain 13 42 0.4× 16 0.2× 128 2.1× 8 0.1× 10 0.2× 30 534
Rachel Howard United States 11 62 0.6× 8 0.1× 191 3.1× 24 0.4× 5 0.1× 20 555
Rory Martin United States 15 24 0.2× 12 0.1× 142 2.3× 13 0.2× 20 0.4× 23 896

Countries citing papers authored by Tetsuro Ito

Since Specialization
Citations

This map shows the geographic impact of Tetsuro Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuro Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuro Ito more than expected).

Fields of papers citing papers by Tetsuro Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuro Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuro Ito. The network helps show where Tetsuro Ito may publish in the future.

Co-authorship network of co-authors of Tetsuro Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuro Ito. A scholar is included among the top collaborators of Tetsuro Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuro Ito. Tetsuro Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
McIntyre, Roger S., István Bitter, Jozefien Buyze, et al.. (2024). Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression. European Neuropsychopharmacology. 85. 58–65. 12 indexed citations
3.
Aldhouse, Natalie V. J., Helen Kitchen, Malcolm Macartney, et al.. (2024). A conceptual model for chronic hepatitis B and content validity of the Hepatitis B Quality of Life (HBQOL) instrument. Journal of Patient-Reported Outcomes. 8(1). 29–29.
4.
Reif, Andreas, István Bitter, Jozefien Buyze, et al.. (2023). Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression. New England Journal of Medicine. 389(14). 1298–1309. 110 indexed citations breakdown →
5.
Oliveira‐Maia, Albino J., et al.. (2023). Treatment-Resistant Depression in Real-World Clinical Practice: A Systematic Literature Review of Data from 2012 to 2022. Advances in Therapy. 41(1). 34–64. 16 indexed citations
6.
Hall, Fiona, et al.. (2019). Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events. Quality of Life Research. 28(5). 1191–1199. 21 indexed citations
7.
Feyerabend, Susan, Fred Saad, Suzy Van Sanden, et al.. (2019). Adjusting Overall Survival Estimates for Treatment Switching in Metastatic, Castration-Sensitive Prostate Cancer: Results from the LATITUDE Study. Targeted Oncology. 14(6). 681–688. 7 indexed citations
8.
9.
10.
11.
Saad, Fred, Tetsuro Ito, Joris Diels, et al.. (2017). Indirect comparison of abiraterone acetate and docetaxel for treatment of metastatic “hormone-sensitive” prostate cancer. Annals of Oncology. 28. v277–v277. 3 indexed citations
12.
13.
Ito, Tetsuro, et al.. (2016). Utility By Treatment Line In Multiple Myeloma; Analysis of Over 9000 EQ-5Q-3L Questionnaires from the Emmos Registry. Value in Health. 19(7). A348–A348. 2 indexed citations
14.
15.
16.
Abe, Yuki, et al.. (2014). Tolerant Sharing of a Single-user Application Among Multiple Users in Collaborative Work.
17.
Backx, Matthijs, Jonathan White, Joby Cole, et al.. (2013). The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1–infected patients who do or do not achieve sustained virological response to therapy. Journal of Viral Hepatitis. 21(3). 208–215. 27 indexed citations
18.
19.
Sampattavanich, Somponnat, et al.. (1990). Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines, and Korea.. PubMed. 58(1). 1–11. 15 indexed citations
20.
Ito, Tetsuro, et al.. (1958). Biochemical Studies on the Murine Leprosy Bacillus. II. Respiration and Respiration Accelerating Substances.. OUKA (Osaka University Knowledge Archive) (Osaka University). 1(2). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pallav Bhatnagar Breakdown of academic impact, for papers by Boris Oskotsky Breakdown of academic impact, for papers by Brian Hurley Breakdown of academic impact, for papers by Matthew M. Hutmacher Breakdown of academic impact, for papers by Carol Reid Breakdown of academic impact, for papers by Enrique J. deAndrés‐Galiana Breakdown of academic impact, for papers by Rachel Howard Breakdown of academic impact, for papers by Rory Martin
Rankless by CCL
2026